NEFL and Parkinson disease: It has recently been demonstrated that cerebrospinal fluid (CSF) and plasma neurofilament light chain (NfL) represent the most effective blood marker for predicting disease progression in several neurodegenerative disorders, including Parkinson’s disease (PD) [5–8].